Combining an anti-angiogenesis agent with an immunotherapy agent, has shown promising anti-tumour activity in an early phase clinical trial in patients with advanced kidney cancer.
Researchers said that it is due to the high energy requirements of livestock farming as well as the very large contribution of livestock to greenhouse gas emissions.
The therapy proved to be effective in lung tissue repair after being used on six patients suffering from interstitial lung diseases and two with bronchiectasis.